Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects

Department of Medical Sciences, Cardiology, Uppsala University Hospital, S-751 85 Uppsala, Sweden.
European Heart Journal (Impact Factor: 14.72). 08/2008; 29(18):2252-8. DOI: 10.1093/eurheartj/ehn327
Source: PubMed

ABSTRACT To evaluate the prevalence of cardiac troponin I (cTnI) elevation in an elderly community population and the association of cTnI levels with cardiovascular risk factors, vascular inflammation, atherosclerosis, cardiac performance, and areas indicative of infarcted myocardium identified by cardiac magnetic resonance imaging.
cTnI elevation defined as cTnI levels >0.01 microg/L (Access AccuTnI, Beckman Coulter) was found in 21.8% of the study participants (n = 1005). cTnI > 0.01 microg/L was associated with cardiovascular high-risk features, the burden of atherosclerosis in the carotid arteries, left-ventricular mass, and impaired left-ventricular systolic function. No associations were found between cTnI and inflammatory activity, diastolic dysfunction, or myocardial scars. Male gender (OR 1.6; 95% CI 1.1-2.4), ischaemic ECG changes (OR 1.7; 95% CI 1.1-2.7), and NT-pro-brain natriuretic peptide levels (OR 1.4; 95% CI 1.1-1.7) independently predicted cTnI > 0.01 microg/L. cTnI > 0.01 microg/L correlated also to an increased cardiovascular risk according to the Framingham risk score.
cTnI > 0.01 microg/L is relatively common in elderly subjects and is associated with cardiovascular high-risk features and impaired cardiac performance. Cardiac troponin determined by a highly sensitive assay might thus serve as an instrument for the identification of subjects at high cardiovascular risk in general populations.

Download full-text


Available from: Bertil Lindahl, Jun 29, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The presence of the cardiospecific cardiac troponins (cTns) I (cTnI) and T (cTnT) alongside signs or symptoms of myocardial infarction (MI) are indicative of an acute MI. As these proteins are not typically found in the sera of healthy individuals, any concentration of cTns exceeding the 99th percentile is interpreted as myocardial necrosis. Recently, new cTnI and cTnT with increased sensitivity and precision have been introduced to improve the detection and diagnosis of acute MI, the newest of which, the Elecsys® Troponin T highly sensitive assay, has demonstrated a particular advantage with high precision even in the 99th percentile. These enhanced properties are expected to increase the incidence of MI diagnoses, but currently it is not clear how to approach therapy in response to the detection of cTnT levels. The detection of elevated cTn levels alone is not sufficient for a diagnosis of acute MI, and requires an in-depth assessment of clinical presentation to determine the source and severity of myocardial damage.
    01/2009; 5(2). DOI:10.15420/ECR.2009.5.2.44
  • [Show abstract] [Hide abstract]
    ABSTRACT: Mesoporous TiO2 powders were synthesized in the presence of surfactant-type pore-directing agents. Monolaureth phosphate was used as the pore-directing agent because of its low cost and industrial convenience. Mesoporous TiO2 was successfully obtained by stabilizing the titanium source with acetylacetone and by hydrolyzing it in strong acidic condition. The crystallinity of hexagonal arranged meso-structure was improved by adding butanol as a co-surfactant and post-treatment with ammonia solution. Several methods were used to remove the organic templates in the structure, and their effect on the porous structure and surface area was compared. The photo-catalytic activity of the resultant porous TiO2 in degradation of phenol was also studied.
  • Source
    Journal of the American College of Cardiology 01/2005; 44(11):2099-110. DOI:10.1016/j.jacc.2004.06.077 · 15.34 Impact Factor